NRx Pharmaceuticals announced the date for its 2025 Annual Meeting, set for March 23, 2026. The meeting will be held in a virtual-only format. Stockholders of record as of February 12, 2026, are entitled to notice and voting rights at the meeting.
2025 Annual Meeting Details
Scheduled for March 23, 2026, at 10:00 a.m. Eastern Time in virtual format.
Record Date
February 12, 2026, set as the record date for stockholders to be notified and vote.
Proposal Deadline
Stockholder proposals must be submitted by January 26, 2026, in accordance with Bylaws.
- The meeting date announcement allows stockholders to prepare for participation. Stockholders are urged to adhere to the submission deadlines for proposals and nominations. Compliance with the Bylaws ensures timely consideration of proposals and nominations.
NRx Pharmaceuticals' proactive approach in disclosing the Annual Meeting details and submission deadlines demonstrates transparency and commitment to shareholder engagement.